Updated Jul 16, 2026
Lavelle Erin has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Erin Lavelle is associated with Avalyn Pharma Inc., a biotechnology company focused on developing therapies for pulmonary diseases. Specific details about her role and contributions within the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Erin Lavelle is associated with Avalyn Pharma Inc., a biotechnology company focused on developing therapies for pulmonary diseases. Specific details about her role and contributions within the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lavelle Erin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.